• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

VCs in $75m round for Kaia Health

  • Harriet Matthews
  • Harriet Matthews
  • 29 April 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

A consortium of VCs including Balderto Capital and Idinvest has backed a $75m funding round for Kaia Health, an AI-based platform that provides therapy and rehabilitation for chronic conditions.

A further undisclosed growth investor led the round, according to a statement from existing investor 3VC. The round also saw participation from all of the company's existing investors, 3VC, Optum Ventures, Balderton Capital, Heartcore Capital and Rory McIlroy's Symphony Ventures.

The company aims to grow its product offering and continue its growth following the round.

Kaia Health

  • DEAL:

    Expansion

  • VALUE:

    $75m

  • LOCATION:

    Munich

  • SECTOR:

    Software

  • FOUNDED:

    2016

Co-founder and CEO Konstantin Mehl told Unquote sister publication Mergermarket in June 2020 that Kaia would reassess its capital needs within the next sixth months, with another funding round expected in 12-15 months' time. He also said that the series-B amount of $26m represented around 15-25% of the company's valuation at that time.

The deal is the largest funding round for a digital health startup recorded in the DACH region to date in 2021, according to Unquote Data. In fact, data for the past five years in the DACH region shows that no other digital startup has raised a round of this size in the past five years.

Previous funding
42Cap and Otto Capital led a $4m seed round for Kaia Health in June 2016.

Balderton Capital led a $10m round for Kaia in January 2019, deploying equity via Balderton VI, which held a final close in November 2017 on $375m.

Optum led a further $8m round for Kaia in September 2019.

Optum, Idinvest and 3VC (then known as Capital300) led a $26m funding round for the company in June 2020. Existing investors Balderton, Heartcore and Symphony also participated.

Company
Kaia was founded in 2016. It is headquartered in Munich, with additional operations in New York. The company provides online therapy courses to treat and provide rehabilitation for chronic conditions including musculoskeletal pain and pulmonary illnesses such as chronic obstructive pulmonary disease. Its AI-based platform uses motion-capture software to monitor patients' movements and provide instructions.

People
Kaia Health – Konstantin Mehl (co-founder, CEO); Manuel Thurner (co-founder).
Optum Ventures – Heather Roxborough (partner).
Idinvest – Antoine Zins (venture capital investor); Matthieu Baret (managing partner).
3VC – Peter Lasinger (general partner).
Balderton Capital – James Wise (partner).
Heartcore Capital – Christian Jepsen (partner).

Advisers
Company – Dentons (legal); Cooley (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • DACH
  • Technology
  • Healthcare
  • Venture
  • Germany
  • Balderton Capital
  • IDInvest Partners (AGF Private Equity)

More on Expansion

Wealth managers and financial advisers
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
Risk and compliance management services
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 3 July 2023

Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
Valentina Vitali of Limerston Capital
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies

UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given

  • GPs
  • 07 June 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013